phenylalanine has been researched along with Cancer of Prostate in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (9.09) | 18.7374 |
1990's | 2 (9.09) | 18.2507 |
2000's | 10 (45.45) | 29.6817 |
2010's | 5 (22.73) | 24.3611 |
2020's | 3 (13.64) | 2.80 |
Authors | Studies |
---|---|
Ben Kacem, M; Bright, SJ; Flint, DB; Kolachina, RV; Lee, CL; Manandhar, M; Martin, TJ; Martinus, DKJ; Morrison, K; Sawakuchi, GO; Shaitelman, SF; Titt, U | 1 |
Ahmad, M; Ben-David, Y; Cheng, S; Li, L; Luo, H; Wan, X; Wu, C; Xu, B; Yang, M; Yu, J | 1 |
Ahmad, M; Cheng, S; Hu, L; Liu, B; Luo, H; Xu, BX; Yu, J; Zhang, D | 1 |
Anselmino, N; Chiarella, P; Contin, MD; Cotignola, J; D Accorso, N; Giudice, J; Gueron, G; Jaworski, F; Labanca, E; Lage Vickers, S; Leonardi, D; Manzano, V; Meiss, RP; Montagna, DR; Navone, N; Ortiz, EG; Paez, AV; Ruggiero, R; Strazza, A; Vazquez, E; Woloszynska-Read, A | 1 |
Beckford-Vera, DR; Blaha, C; Blecha, JE; Evans, MJ; Flavell, RR; Fogarty, M; Hayes, TR; Hong, AS; Hope, TA; Huynh, T; Ozawa, T; Raleigh, DR; Santos, R; VanBrocklin, HF; Wang, S; Wilson, DM | 1 |
Chandrasekhar, S; Mahipal, B; Singh, A; Ummanni, R | 1 |
Berkman, CE; Black, ME; Fulton, MD; Ganguly, T; Hopkins, MR; Martin, SE; Munske, GR | 1 |
Azuma, H; Hirano, H; Ibuki, N; Inamoto, T; Kawabata, S; Kirihata, M; Kiyama, S; Kuroiwa, T; Minami, K; Miyatake, S; Nomi, H; Suzuki, M; Takahara, K; Takai, T; Yoshikawa, Y | 1 |
Fu, X; Fu, YM; Ge, X; Li, YQ; Meadows, GG; Sanchez, PJ; Yu, ZX | 1 |
Asakuma, J; Asano, T; Hayakawa, M; Nanus, DM; Sumitomo, M | 1 |
Liu, H; Meadows, GG; Núñez, NP | 1 |
Förbs, D; Schweinitz, A; Steinmetzer, T; Stella, MC; Stürzebecher, A; Stürzebecher, J; Thiel, S; Uhland, K | 1 |
Bai, YJ; Hao, XK; Liu, JY; Wu, GJ; Yin, Y; Yue, QH | 1 |
Bode, W; Dönnecke, D; Friedrich, R; Müller, F; Schuster, O; Schweinitz, A; Steinmetzer, P; Steinmetzer, T; Stürzebecher, A; Stürzebecher, J; Than, ME; Uhland, K | 1 |
Bowden, GT; Bretton, L; Knox, JD; Lynch, T; Nagle, RB | 1 |
Borchert, D; Hasan, T; Jung, K; Le, DK; Lein, M; Loenings, SA; Ortel, B; Schnorr, D; Winkelmann, B | 1 |
Chen, Y; Hao, XK; Shi, PT; Tao, QY; Zhang, YH | 1 |
Ge, X; Meadows, GG; Zhang, H | 1 |
Anderson, RL; Bissell, MJ; Le Beyec, J | 1 |
Bhagat, S; Che, M; Cher, ML; Fridman, R; Herzog, M; Mullins, C; Nemeth, JA; Shekarriz, B; Upadhyay, J; Yousif, R | 1 |
Bodansky, O; Fleisher, M; Schwartz, MK | 1 |
Mainwaring, WI; Williams, DC | 1 |
22 other study(ies) available for phenylalanine and Cancer of Prostate
Article | Year |
---|---|
Effect of boron compounds on the biological effectiveness of proton therapy.
Topics: Boron Compounds; Boron Neutron Capture Therapy; Humans; Male; Phenylalanine; Prostatic Neoplasms; Proton Therapy; Protons; Relative Biological Effectiveness | 2022 |
A Novel L-Phenylalanine Dipeptide Inhibits the Growth and Metastasis of Prostate Cancer Cells via Targeting DUSP1 and TNFSF9.
Topics: 4-1BB Ligand; Apoptosis; Biological Products; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dipeptides; Dual Specificity Phosphatase 1; Humans; Interleukin-6; Male; Molecular Docking Simulation; Phenylalanine; Prostatic Neoplasms; Proteomics; Serpin E2 | 2022 |
A novel L-phenylalanine dipeptide inhibits prostate cancer cell proliferation by targeting TNFSF9.
Topics: 4-1BB Ligand; Apoptosis; Cell Line, Tumor; Cell Proliferation; Humans; Interleukin-6; Male; Phenylalanine; Prostatic Hyperplasia; Prostatic Neoplasms | 2023 |
Game-changing restraint of Ros-damaged phenylalanine, upon tumor metastasis.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Drug Resistance, Neoplasm; Humans; Male; Mice, Nude; Neoplasm Metastasis; Phenylalanine; Prostatic Neoplasms; Reactive Oxygen Species; Serum; Signal Transduction; Subcutaneous Tissue; Tyrosine; Xenograft Model Antitumor Assays | 2018 |
Synthesis and Initial Biological Evaluation of Boron-Containing Prostate-Specific Membrane Antigen Ligands for Treatment of Prostate Cancer Using Boron Neutron Capture Therapy.
Topics: Animals; Antigens, Surface; Boron Compounds; Boron Neutron Capture Therapy; Boronic Acids; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Glutamate Carboxypeptidase II; Humans; Inhibitory Concentration 50; Ligands; Male; Mice; Mice, Nude; Oligopeptides; Phenylalanine; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiation-Sensitizing Agents; Tissue Distribution; Xenograft Model Antitumor Assays | 2019 |
5-epi-Torrubiellutin C shows antiproliferative activity on DU145 prostate cancer cells through inactivation of the AKT/mTOR pathway.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Lactams, Macrocyclic; Male; Phenylalanine; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases | 2014 |
Development of inhibitor-directed enzyme prodrug therapy (IDEPT) for prostate cancer.
Topics: Antigens, Surface; Antineoplastic Agents; Azides; Cell Line, Tumor; Click Chemistry; Drug Delivery Systems; Glutamate Carboxypeptidase II; Humans; Male; Phenylalanine; Prodrugs; Prostate; Prostatic Neoplasms | 2014 |
The Anti-Proliferative Effect of Boron Neutron Capture Therapy in a Prostate Cancer Xenograft Model.
Topics: Animals; Apoptosis; Boron Compounds; Boron Neutron Capture Therapy; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Radiation; Humans; Male; Mice; Mice, Nude; Neutrons; Phenylalanine; Prostatic Neoplasms; Xenograft Model Antitumor Assays | 2015 |
Specific amino acid dependency regulates invasiveness and viability of androgen-independent prostate cancer cells.
Topics: Amino Acids; Androgens; Animals; Apoptosis; Cell Adhesion; Cell Cycle; Cell Division; Cell Line, Tumor; DNA Fragmentation; Flow Cytometry; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Humans; Male; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Phenylalanine; Phosphorylation; Prostatic Neoplasms; Protein-Tyrosine Kinases; Tyrosine | 2003 |
Chemosensitization of androgen-independent prostate cancer with neutral endopeptidase.
Topics: Androgens; Annexin A5; Antineoplastic Agents, Phytogenic; Apoptosis; Cells, Cultured; Drug Resistance, Neoplasm; Epithelial Cells; Etoposide; Humans; Male; Mitochondria; Neoplasms, Hormone-Dependent; Neprilysin; Organophosphonates; Phenylalanine; Prostate; Prostatic Neoplasms; Protein Kinase C; Protein Kinase C-delta; Recombinant Proteins | 2004 |
PPAR-gamma ligands and amino acid deprivation promote apoptosis of melanoma, prostate, and breast cancer cells.
Topics: Amino Acids; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Female; Humans; Hypoglycemic Agents; Immunologic Factors; Ligands; Male; Melanoma; Methionine; Phenylalanine; PPAR gamma; Prostaglandin D2; Prostatic Neoplasms; Thiazolidinediones; Tyrosine | 2006 |
In vitro inhibition of matriptase prevents invasive growth of cell lines of prostate and colon carcinoma.
Topics: Blotting, Western; Catalytic Domain; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Collagen; Colonic Neoplasms; Disease Progression; Dose-Response Relationship, Drug; Drug Combinations; Enzyme Activation; Enzyme Inhibitors; Female; Hepatocyte Growth Factor; Humans; In Vitro Techniques; Inhibitory Concentration 50; Kinetics; Laminin; Male; Models, Chemical; Neoplasm Invasiveness; Neoplasm Metastasis; Peptide Hydrolases; Phenylalanine; Prostatic Neoplasms; Protein Precursors; Protein Structure, Tertiary; Proteoglycans; RNA, Small Interfering; Serine Endopeptidases; Signal Transduction; Time Factors | 2005 |
In vitro and in vivo prodrug therapy of prostate cancer using anti-gamma-Sm-scFv/hCPA fusion protein.
Topics: Animals; Antibodies, Neoplasm; Carboxypeptidases A; Cell Cycle; Cell Line, Tumor; Drug Delivery Systems; Humans; Immunoglobulin Variable Region; Male; Methotrexate; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplastic Stem Cells; Phenylalanine; Prodrugs; Prostate-Specific Antigen; Prostatic Neoplasms; Recombinant Fusion Proteins; Transplantation, Heterologous | 2006 |
Secondary amides of sulfonylated 3-amidinophenylalanine. New potent and selective inhibitors of matriptase.
Topics: Amides; Amidines; Animals; Catalytic Domain; Crystallography, X-Ray; Humans; Kinetics; Male; Mice; Mice, Nude; Models, Molecular; Neoplasm Metastasis; Phenylalanine; Prostatic Neoplasms; Serine Endopeptidases; Serine Proteinase Inhibitors; Structure-Activity Relationship; Sulfones; Xenograft Model Antitumor Assays | 2006 |
Synthetic matrix metalloproteinase inhibitor, BB-94, inhibits the invasion of neoplastic human prostate cells in a mouse model.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma in Situ; Humans; Male; Metalloendopeptidases; Mice; Mice, SCID; Neoplasm Invasiveness; Phenylalanine; Prostatic Neoplasms; Protease Inhibitors; Thiophenes; Transplantation, Heterologous; Tumor Cells, Cultured | 1998 |
Synthetic inhibitor of matrix metalloproteinases (batimastat) reduces prostate cancer growth in an orthotopic rat model.
Topics: Animals; Antineoplastic Agents; Cell Division; Dose-Response Relationship, Drug; Male; Neoplasm Transplantation; Phenylalanine; Prostatic Neoplasms; Rats; Thiophenes; Tumor Cells, Cultured | 2000 |
[The solid-phase synthesis of methotrexate-alpha-peptides].
Topics: Antineoplastic Agents; History, Medieval; Humans; Male; Methotrexate; Phenylalanine; Prodrugs; Prostatic Neoplasms; Tumor Cells, Cultured | 1997 |
Specific amino acid deficiency alters the expression of genes in human melanoma and other tumor cell lines.
Topics: Blotting, Western; Breast Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Male; MAP Kinase Kinase 4; MAP Kinase Signaling System; Melanoma; Mitogen-Activated Protein Kinase Kinases; Phenylalanine; Phosphorylation; Prostatic Neoplasms; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured; Tyrosine | 2001 |
Prostate cancer in bone: importance of context for inhibition of matrix metalloproteinases.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Disease Models, Animal; Humans; Male; Matrix Metalloproteinase Inhibitors; Neoplasm Metastasis; Phenylalanine; Prostatic Neoplasms; Thiophenes | 2002 |
Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Bone Remodeling; Bone Transplantation; Calcium; Disease Models, Animal; Fetal Tissue Transplantation; Humans; Immunohistochemistry; In Situ Hybridization; Male; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Mice, SCID; Neoplasm Metastasis; Oligonucleotide Probes; Osteoclasts; Phenylalanine; Prostatic Neoplasms; RNA, Messenger; Thiophenes; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2002 |
Clinical application of phosphohydrolase measurements in cancer.
Topics: Acid Phosphatase; Alkaline Phosphatase; Bile Acids and Salts; Bone Neoplasms; Electrophoresis; Histidine; Humans; Hydrogen-Ion Concentration; Kidney; Liver; Male; Neoplasms; Nucleotidases; Organ Specificity; Phenylalanine; Phosphoric Monoester Hydrolases; Prostatic Neoplasms | 1969 |
The effect of castration on the ribonucleic acid metabolism of an experimental prostatic tumour.
Topics: Adenosine Triphosphate; Animals; Benz(a)Anthracenes; Castration; Cell Nucleus; In Vitro Techniques; Male; Microsomes; Neoplasm Proteins; Neoplasm Transplantation; Neoplasms, Experimental; Nucleotidyltransferases; Phenylalanine; Prostatic Neoplasms; Rats; RNA, Neoplasm | 1966 |